03:29 PM EDT, 07/07/2025 (MT Newswires) -- Health care stocks declined late Monday afternoon with the NYSE Health Care Index shedding 0.9% and the Health Care Select Sector SPDR Fund (XLV) falling 1.1%.

The iShares Biotechnology ETF (IBB) dropped 1.6%.

In sector news, Alphabet's (GOOG) Isomorphic Labs is preparing to start human trials of its AI-designed drugs, Fortune reported, citing Isomorphic Labs President Colin Murdoch. The report said Isomorphic has signed deals with companies such as Novartis (NVS) and Eli Lilly (LLY) and has been working in areas like oncology and immunology.

In corporate news, GSK (GSK) completed its acquisition of Boston Pharmaceuticals' steatotic liver disease therapeutic candidate efimosfermin. GSK shares added 0.1%.